CeriBell, Inc. (CBLL) vs Cytek Biosciences, Inc. (CTKB)
CeriBell, Inc. and Cytek Biosciences, Inc. are both Medical Devices companies. CeriBell, Inc. is the larger, with a market value of $914.2M against $744.8M — 1.2× the size. CeriBell, Inc. grew revenue faster over the last twelve months: 31.7% against 5.44%. Cytek Biosciences, Inc. has the higher net margin (−39.0% vs −64.7%) and the higher return on invested capital (−46.4% vs −229.8%). Across the 17 metrics below, Cytek Biosciences, Inc. leads on 11 and CeriBell, Inc. on 6.
Valuation
Profitability
| Metric | CBLL | CTKB | Medical Devices median |
|---|---|---|---|
| Gross margin | 88.90% | 53.23% | 56.01% |
| Operating margin | (68.62%) | (21.60%) | (15.03%) |
| Net margin | (64.73%) | (38.98%) | (20.40%) |
| Free cash flow margin | (55.02%) | (5.79%) | (7.24%) |
| Return on equity | (43.93%) | (23.04%) | (15.32%) |
| Return on assets | (35.29%) | (17.14%) | (19.72%) |
| Return on invested capital | (229.76%) | (46.36%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack